Table 4.
Cox regression models for risk factors associated with the endpoint.
| Model | Variable | HR | 95% CI | P |
|---|---|---|---|---|
| Model 1 | Sex | 1.80 | 0.91, 3.56 | 0.090 |
| Age | 1.02 | 0.93, 1.04 | 0.186 | |
| PFT | 2.91 | 1.16, 7.30 | 0.023 | |
|
| ||||
| Model 2 | Sex | 1.53 | 0.72, 3.28 | 0.147 |
| Age | 1.040 | 0.94, 1.11 | 0.424 | |
| Hypertension | 2.57 | 0.77, 4.20 | 0.113 | |
| Diabetes course | 1.13 | 0.94, 1.27 | 0.201 | |
| Insulin therapy | 0.48 | 0.25, 0.93 | 0.029 | |
| Antihypertensive drugs | 0.25 | 0.08, 0.83 | 0.024 | |
| Hypolipidemic therapy | 0.39 | 0.11, 1.11 | 0.152 | |
| PFT | 2.89 | 1.14, 7.50 | 0.026 | |
|
| ||||
| Model 3 | Sex | 1.39 | 0.66, 2.21 | 0.440 |
| Age | 1.01 | 0.99, 1.03 | 0.254 | |
| Diabetes course | 1.04 | 0.98, 1.05 | 0.511 | |
| Hypertension | 2.26 | 1.18, 3.38 | 0.014 | |
| Insulin therapy | 0.41 | 0.21, 0.67 | 0.005 | |
| Antihypertensive drugs | 1.44 | 0.81, 2.04 | 0.866 | |
| Hypolipidemic therapy | 2.11 | 0.41, 3.83 | 0.890 | |
| PFT | 2.83 | 1.34, 4.88 | <0.001 | |
| BMI | 1.04 | 0.97, 1.11 | 0.288 | |
| PFT/BMI | 1.20 | 1.03, 1.40 | 0.017 | |
| HbA1C | 1.20 | 1.11, 1.26 | <0.001 | |
| ALB | 1.03 | 0.98, 1.08 | 0.259 | |
| eGFR | 0.98 | 0.97, 0.99 | <0.001 | |
| UACR | 1.06 | 1.01, 1.12 | 0.026 | |
Hypertension: history of hypertension; HbA1C: glycated hemoglobin ratio; FPG: fasting plasma glucose; UACR: urinary creatinine protein ratio; ALB: serum albumin; urea: serum urea nitrogen; SCr: blood creatinine; UA: blood uric acid; Tch: total serum cholesterol; TG: triglycerides; HDL: serum high-density lipoprotein; LDL: serum low-density lipoprotein; eGFR: predicted glomerular filtration rate; PFT: perirenal fat thickness.